Andrew Egger and Jonathan Cohn give their takes on the stunning back-and-forth at the FDA over Moderna’s new mRNA flu vaccine, why the agency initially refused to even review the application, and what ...
A challenging public health policy landscape under health secretary Robert F. Kennedy has vaccine makers rethinking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results